| Spencer James Lucas, | |
|
169 Ashley Ave Rm 202, Charleston, SC 29425-8905 | |
| (843) 792-5976 | |
| Not Available |
| Full Name | Spencer James Lucas |
|---|---|
| Gender | Male |
| Speciality | Surgery - Vascular Surgery |
| Location | 169 Ashley Ave Rm 202, Charleston, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407545643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | X (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Spencer James Lucas, 169 Ashley Ave Rm 202, Charleston, SC 29425-8207 Ph: (843) 792-5976 | Spencer James Lucas, 169 Ashley Ave Rm 202, Charleston, SC 29425-8905 Ph: (843) 792-5976 |
News Archive
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009.
In response to adverse event reports received by ECRI Institute PSO and to promote such learning, ECRI Institute PSO has begun disseminating periodic Patient Safety E-lerts to participating organizations. The Patient Safety E-lert will bring attention to these issues and is concisely formatted to stimulate discussion and action by interdisciplinary committees focused on reducing the risk of healthcare events.
Raptor Pharmaceutical Corp. announced that it has enrolled the first patient in a pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
Several cancer tumors grow through immunosuppression; that is, they manipulate biological systems in their microenvironments and signal to a specific set of immune cells-those that clear out aberrant cells-to stop acting. It is no wonder that immunotherapy designed to re-establish anti-tumor immunity is rapidly becoming the treatment of choice for these cancers.
Pop a bubble while washing the dishes and you're likely to release a few drops of water trapped when the soapy sphere formed. A few years ago, researchers at the National Institute of Standards and Technology pioneered a method using a microscopic fluidic (microfluidic) device that exploits the same principle to create liquid-filled vesicles called liposomes from phospholipids, the fat complexes that are the building blocks for animal cell membranes
› Verified 7 days ago
Dr. Michael Charles O'laughlin, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-3072 | |
Kyler Perry, DO Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2300 | |
Dr. Swathi Venattu, MD Surgery Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Antwana Sharee Wright, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Jacob Arthur Klapper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Norman Robert Harvey, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-2123 | |
Hyejin Kwon, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave, Charleston, SC 29425 Phone: 843-792-3072 |